| Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224) |
|---|
| 05/22/2002 | EP0676960B1 Cycloalkyl amine bis-aryl squalene synthase inhibitors |
| 05/22/2002 | CN1350523A Indoline derivatives as progesterohe antagonists |
| 05/22/2002 | CN1350520A Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds |
| 05/22/2002 | CN1350512A Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use |
| 05/21/2002 | US6392103 Using organometallic compound as catalyst |
| 05/21/2002 | US6392067 Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors |
| 05/21/2002 | US6391918 N-sulphonyl and N-sulphinyl phenylglycinamide |
| 05/21/2002 | US6391907 Anticancer agents; contraceptives |
| 05/21/2002 | CA2039706C Method for preparing amino acid derivatives and therapeutical applications of same |
| 05/16/2002 | WO2002038534A2 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases |
| 05/16/2002 | WO2001098291A3 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 05/16/2002 | US20020058823 Dehydrationg cyclohexylalcohol compound |
| 05/16/2002 | US20020058698 Reacting aglycone intermediate with methanesulfonic acid to form pseudopterosin compound |
| 05/16/2002 | US20020058670 Glycosylating purine or pyrimidine base low temperature with an intermediate to for producing a beta -nucleoside analogue |
| 05/16/2002 | US20020056827 Piezoelectric element and process for production thereof |
| 05/16/2002 | CA2428266A1 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases |
| 05/15/2002 | EP1205476A1 Process for the synthesis of N-(mercaptoacyl)-amino acids derivatives from alpha-substituted acrylic acids |
| 05/15/2002 | EP1204632A1 Fungicidal compounds having a fluorovinyl- or fluoropropenyl-oxyphenyloxime moiety and process for the preparation thereof |
| 05/15/2002 | EP1164122A9 Process for producing fluorine compound through liquid-phase fluorination |
| 05/15/2002 | CN1349507A Pyridine-2,3-dicarboxylic acid diamides |
| 05/15/2002 | CN1349498A Alkenyl-and alkynyl-containing metalloprotease inhibitors |
| 05/15/2002 | CN1349485A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 05/15/2002 | CN1084742C Process for preparing 3-phenyl-1-methylenedioxyphenyl-indame-2-carboxylic acid derivatives |
| 05/14/2002 | US6388104 4-methylene-1,3-dioxolanes having functional groups |
| 05/14/2002 | US6387934 2-Cyano-3,5-dihydroxyhex-2-enecarboxamide derivatives |
| 05/14/2002 | US6387906 Dermatophytes |
| 05/14/2002 | US6387897 Preferentially substituted calcium channel blockers |
| 05/14/2002 | US6387431 Dicarboalkoxy dioxolanes as flavoring agent releasing compounds |
| 05/14/2002 | US6387223 Distillation, circulation; purification |
| 05/10/2002 | WO2002036533A1 Monomers having electron-withdrawing groups and processes for preparing the same |
| 05/09/2002 | US20020055645 Process for synthesizing N-(mercaptoacyl) amino acid derivatives from alpha-substituted acrylic acids |
| 05/09/2002 | US20020055631 N-acylsulfonamide apoptosis promoters |
| 05/09/2002 | US20020055522 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
| 05/08/2002 | EP1203766A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 05/08/2002 | EP1203764A1 Benzamidine derivatives with LTB4-antagonistic activity |
| 05/08/2002 | EP1202968A2 Antibacterial agents |
| 05/08/2002 | EP1202953A2 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 05/08/2002 | CN1348441A N-substituted arylsulfonyl-lamino hydroxamic acids |
| 05/08/2002 | CN1347693A Noval compound, its synthetizing process and therapeutic use |
| 05/07/2002 | US6384247 Method of producing sesamol formic acid ester and sesamol |
| 05/07/2002 | US6384240 Process for the purification of alkylene carbonate |
| 05/07/2002 | US6384239 Method for producing monohalogenated 2-oxo-1,3-dioxolanes |
| 05/07/2002 | US6384080 Anthranilic acid derivatives as inhibitors of the cGMP-phosphodiesterase |
| 05/07/2002 | US6384075 Treating diseases in which mast cell dysfunction is involved |
| 05/07/2002 | US6384036 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 05/02/2002 | WO2002034740A1 Method for producing cyclic carboxylic orthoester fluorides and corresponding compounds |
| 05/02/2002 | WO2002034711A1 Biaryl compounds as serine protease inhibitors |
| 05/02/2002 | WO2001096283A3 Hiv integrase inhibitors |
| 05/02/2002 | US20020052531 Hydroformylation of olefins using supported bis (phosphorus) ligands |
| 05/02/2002 | US20020052530 Such as 3-(N-1-indanylamino)-indan-1-one 3-(N-1-indanylamino) indan-1-one formed by reacting amino-indane compound with bromo-indanone compound in presence of triethyleneamine |
| 05/02/2002 | US20020052399 In particular as inhibitors of HIV protease. |
| 05/02/2002 | US20020052370 Including the treatment of female sexual dysfunction especially female sexual arousal disorder |
| 05/02/2002 | US20020052343 Salicylamides as serine protease inhibitors |
| 05/02/2002 | EP1200442A1 2,3-benzodiazepine derivatives |
| 05/02/2002 | EP1200395A1 Urea derivatives as inhibitors of ccr-3 receptor |
| 05/02/2002 | EP0765336B1 Synthesis of conduritol epoxides and aziridines and methods of using such to synthesize higher disaccharides |
| 05/02/2002 | CA2426430A1 Biaryl compounds as serine protease inhibitors |
| 04/30/2002 | US6380447 Pressurization; forming bicyclic compounds |
| 04/30/2002 | US6380403 Illudin analogs useful as antitumor agents |
| 04/30/2002 | US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 04/30/2002 | US6380223 For therapy of diseases, such as obesity, diabetes, inflammation |
| 04/30/2002 | US6380188 For inhibiting human immunodeficiency virus protease |
| 04/30/2002 | US6379895 Photolithographic and other means for manufacturing arrays |
| 04/30/2002 | US6379590 Method for making unsymmetrically substituted fluorenyl compounds for nonlinear optical applications |
| 04/30/2002 | CA2187277C Novel derivative of ester of carboxylic acid, the process of manufacturing the same, and insecticide and insect proofing agent containing the same |
| 04/25/2002 | WO2002032844A2 Epothilone synthesis components iii and iv: asymmetrically substituted acyloins and acyloin derivatives, method for the production thereof and method for the production of epithilone b, d and epothilone derivatives |
| 04/25/2002 | WO2002032417A1 Pharmaceutical preparations containing a dibenzocyclooctane lignan derivative for prevention and treatment of neurodegenerative disease |
| 04/25/2002 | US20020049288 Metal-ligand complex precursor composition of an amine containing ligand of given formula and group 3,4, or lanthanide metal compound; polymerizing alpha-olefins, higher comonomer content of C4+ olefins |
| 04/25/2002 | US20020049226 Treating obesity, hyperlipidemia, glaucoma, arrhythmia, skin disorders, thyroid disease, hypothyroidism, diabetes mellitus, atherosclerosis, hypertension, coronary heart disease, hypercholesteremia, depression and osteoporosis |
| 04/25/2002 | US20020049221 Analogs of deoxypreussomerin, palmarumycin CPI and related naphthoquinone spiroketals; inhibit thioredoxin-thioredoxin reductase system |
| 04/25/2002 | US20020049209 Dopamine D4 ligands for the treatment of novelty-seeking disorders |
| 04/25/2002 | US20020048589 Extracts from the fungus guignardia sp., their uses in pharmaceutical compositions, new isolate compound from the extract of the fungus gignardia sp. and its use in pharmaceutical compositions |
| 04/24/2002 | EP1198451A2 Substituted phenoxyacetic acids |
| 04/24/2002 | CN1083450C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides |
| 04/24/2002 | CN1083448C 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (D4) |
| 04/24/2002 | CN1083422C Process for production of phenyllatic acid derivative |
| 04/23/2002 | US6376684 Chemical intermediate for oxybutynin-type compounds |
| 04/23/2002 | US6376538 Antiinflammatory agents; autoimmune diseases |
| 04/23/2002 | US6376535 Oxygen-containing heterocyclic compounds |
| 04/23/2002 | US6376428 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production |
| 04/18/2002 | WO2002030929A1 Novel pleuromutilin derivatives |
| 04/18/2002 | WO2002030879A2 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
| 04/18/2002 | WO2002012166A3 Triamine derivative melanocortin receptor ligands and methods of using same |
| 04/18/2002 | WO2002003995A3 Treatment of male sexual dysfunction |
| 04/18/2002 | US20020045777 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes. |
| 04/18/2002 | US20020045769 Novel acyclic chiral derivatives of hibiscus acid and the process of preparing the same |
| 04/18/2002 | US20020045768 Preparation of cyclohexene derivatives intermediates for carotinoids using a mixture of zinc and a salt of ammonium, copper, alkali metal or alkaline earth metal as reducing agent |
| 04/18/2002 | US20020045749 Antibacterial agents |
| 04/18/2002 | US20020045674 4-Methylene-1,3-dioxolanes as cross-linking agents |
| 04/18/2002 | US20020045602 7-substituted fused ring tetracycline compounds |
| 04/18/2002 | DE10051136A1 New alpha-hydroxy-ketone derivatives, useful as intermediates for biologically active polyketides, terpenoids, epothilones and their derivatives |
| 04/18/2002 | CA2765409A1 Hydroxamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
| 04/17/2002 | EP1197483A2 Process for the catalytic reduction of alkyne compounds |
| 04/17/2002 | EP1196491A1 Polycarbonate composition resistant to gamma radiation |
| 04/17/2002 | EP1196406A1 Amino ceramide-like compounds and therapeutic methods of use |
| 04/17/2002 | CN1345304A Substituted aniline compounds |
| 04/17/2002 | CN1345303A Oxamic acids and derivatives as thyroid receptor ligands |
| 04/17/2002 | CN1345298A Process for producing fluorine compound through liquid phase fluorination |
| 04/17/2002 | CN1345239A Heterocyclic containing biphenyl alpha P2 inhibitors and method |
| 04/16/2002 | US6372779 Anthracene derivatives with carbamoyl groups, amido groups, urea groups and sulfonamide groups |